TRIM32 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.362830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.865900E-02
Normal-vs-Stage2
1.608600E-01
Normal-vs-Stage3
1.337620E-02
Normal-vs-Stage4
6.852600E-01
Stage1-vs-Stage2
7.803400E-01
Stage1-vs-Stage3
9.500300E-02
Stage1-vs-Stage4
2.771000E-01
Stage2-vs-Stage3
9.479900E-02
Stage2-vs-Stage4
3.152600E-01
Stage3-vs-Stage4
6.515500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.314980E-01
Normal-vs-AfricanAmerican
4.166600E-01
Normal-vs-Asian
1.612600E-01
Caucasian-vs-AfricanAmerican
6.051200E-01
Caucasian-vs-Asian
9.739600E-01
AfricanAmerican-vs-Asian
6.998800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.613630E-01
Normal-vs-Female
1.143450E-01
Male-vs-Female
8.207000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.349950E-01
Normal-vs-Age(41-60Yrs)
4.243800E-01
Normal-vs-Age(61-80Yrs)
6.830300E-02
Normal-vs-Age(81-100Yrs)
4.186100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.017000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.015400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.363000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.583900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.465700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.515000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.252300E-02
Normal-vs-Daily Drinker
1.639540E-02
Normal-vs-Weekly Drinker
7.118200E-02
Normal-vs-Occasional Drinker
3.564000E-01
Normal-vs-Social Drinker
5.635800E-01
Non Drinker-vs-Daily Drinker
7.188800E-01
Non Drinker-vs-Weekly Drinker
5.241400E-01
Non Drinker-vs-Occasional Drinker
1.809840E-01
Non Drinker-vs-Social Drinker
2.003500E-02
Daily Drinker-vs-Weekly Drinker
3.069400E-01
Daily Drinker-vs-Occasional Drinker
1.303550E-01
Daily Drinker-vs-Social Drinker
8.198400E-03
Weekly Drinker-vs-Occasional Drinker
5.211200E-01
Weekly Drinker-vs-Social Drinker
1.138370E-01
Occasional Drinker-vs-Social Drinker
4.328200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.531800E-01
Normal-vs-Grade 2
4.357700E-02
Normal-vs-Grade 3
6.005900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.078250E-02
Grade 1-vs-Grade 3
1.309630E-02
Grade 1-vs-Grade 4
2.531800E-01
Grade 2-vs-Grade 3
5.980800E-01
Grade 2-vs-Grade 4
4.357700E-02
Grade 3-vs-Grade 4
6.005900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.887900E-02
Normal-vs-NonDiabetic
1.518800E-01
Diabetic-vs-NonDiabetic
3.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.143000E-01
Normal-vs-NoPancreatitis
1.298190E-01
Pancreatitis-vs-NoPancreatitis
6.339400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.262790E-01
Normal-vs-N1
1.562360E-01
N0-vs-N1
3.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.118400E-01
Normal-vs-TP53-NonMutant
1.855410E-01
TP53-Mutant-vs-TP53-NonMutant
4.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
